Healthcare

The medical technology sector continues to face significant macroeconomic headwinds, shifting investor focus toward foundational technological progress. In a strategic...

A significant update to U.S. cancer treatment protocols has substantially broadened the potential patient population for ImmunityBio's flagship immunotherapy. The...

Precision Biosciences is progressing its gene therapy candidate for Duchenne muscular dystrophy (DMD), with investor attention now turning to a...

The biotechnology firm Allogene Therapeutics is approaching a critical juncture that will test the long-term viability of its business model....

Biotechnology firm Xilio Development is set to present new preclinical findings for its drug candidate XTX601 at the upcoming American...

New clinical data presented this week by Arvinas at a specialist conference in Copenhagen has marked a significant advance for...

Today marks a significant confluence of events for Healwell AI Inc. The company is releasing its complete fiscal 2025 annual...

The telehealth company Hims & Hers has taken a decisive step into the competitive GLP-1 market. It has now opened...

The company JZZ is strategically aligning its business model to capitalize on the expanding demographic of consumers aged 55 and...

Precision Biosciences is solidifying its clinical development strategy, with a pivotal trial for a Duchenne muscular dystrophy (DMD) treatment taking...